DiVA

diva-portal.org

Digitala Vetenskapliga Arkivet

EnglishSvenskaNorsk
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
A Budget Impact Model Of The Addition Of Telotristat Ethyl Treatment In Patients With Uncontrolled Carcinoid Syndrome
Optum, Boston, MA USA..
Optum, Burlington, ON, Canada..
Optum, Burlington, ON, Canada..
Optum, Burlington, ON, Canada..
Show others and affiliations
2017 (English)In: Value in Health, ISSN 1098-3015, E-ISSN 1524-4733, Vol. 20, no 9, p. A548-A549Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2017. Vol. 20, no 9, p. A548-A549
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-345694ISI: 000413599901196OAI: oai:DiVA.org:uu-345694DiVA, id: diva2:1190962
Available from: 2018-03-16 Created: 2018-03-16 Last updated: 2018-03-16Bibliographically approved

Open Access in DiVA

No full text in DiVA

Search in DiVA

By author/editor
Welin, Staffan
By organisation
Endocrin Oncology
In the same journal
Value in Health
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 344 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
v. 2.47.0
|
WCAG
|
About DiVA Portal
|
About the DiVA Consortium